Sunrest Lifescience
add_icon

Sunrest Lifescience

37.50
0.00
(0.00%)
Market Cap
32.18 Cr
PE Ratio
16.03
Volume
0.00
Day High - Low
- - -
52W High-Low
61.00 - 29.55
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
32.18 Cr
EPS
4.66
PE Ratio
16.03
PB Ratio
1.03
Book Value
36.51
EBITDA
3.00
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
12.36
Debt to Equity
0.41
Forecast For
Actual
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,693.60
#1 4,06,351.37
37.86
#1 54,729.00
9.71
#1 10,980
16.07
37.98
5,856.50
1,55,471.67
63.26
9,712.00
18.67
2,191
-1.02
33.24
3,987.20
1,34,944.97
61.20
11,539.40
6.99
1,911
26.24
32.75
2,274.50
1,03,954.48
22.26
22,909.50
13.74
3,306
#1 37.44
47.35
1,217.30
1,01,601.09
18.27
33,741.20
16.73
5,725
-15.28
39.36
1,192.40
96,319.77
21.31
28,409.50
7.12
5,291
-57.18
26.86
864.25
86,963.77
#1 17.29
23,511.00
18.55
4,615
-0.32
41.42
1,998.50
82,499.09
45.81
12,744.20
#1 20.90
2,007
7.65
41.40
1,333.70
77,461.51
22.37
32,345.60
9.43
3,484
7.59
64.38
5,258.00
62,867.28
25.87
13,458.30
3.70
2,216
1.90
42.54
Growth Rate
Revenue Growth
12.20 %
Net Income Growth
900.00 %
Cash Flow Change
109.66 %
ROE
677.36 %
ROCE
206.96 %
EBITDA Margin (Avg.)
194.16 %

Yearly Financial Results

Annual Financials
2020
2021
2022
2023
2024
2025
TTM
Revenue
11
17
27
25
30
33
19
Expenses
11
17
26
22
29
30
18
EBITDA
0
0
1
3
1
3
1
Operating Profit %
1 %
2 %
4 %
12 %
3 %
9 %
6 %
Depreciation
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
Profit Before Tax
0
0
1
3
1
3
1
Tax
0
0
0
1
0
1
-0
Net Profit
0
0
1
2
0
2
2
EPS in ₹
0.37
1.66
2.59
6.81
0.68
4.66
6.60

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
6
10
13
17
25
35
Fixed Assets
0
0
1
0
0
1
Current Assets
6
9
13
16
25
28
Capital Work in Progress
0
0
0
0
0
0
Investments
0
0
0
0
0
0
Other Assets
6
9
13
16
25
34
Total Equity & Liabilities
6
10
13
17
25
35
Current Liabilities
4
7
9
12
8
15
Non Current Liabilities
2
2
3
2
4
4
Total Equity
0
0
1
3
14
16
Reserve & Surplus
0
0
1
0
10
12
Share Capital
0
0
0
3
4
4

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
0
0
0
-0
0
Investing Activities
0
-0
-0
0
0
-1
Operating Activities
-1
0
-0
1
-15
1
Financing Activities
1
0
1
-1
15
-0

Share Holding

% Holding
Nov 2023
Mar 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
69.91 %
69.91 %
69.91 %
69.91 %
69.91 %
69.91 %
53.50 %
53.50 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
25.24 %
24.46 %
24.87 %
24.83 %
24.94 %
24.27 %
36.02 %
34.90 %
Others
4.85 %
5.63 %
5.22 %
5.26 %
5.15 %
5.82 %
10.48 %
11.60 %
No of Share Holders
742
580
505
487
459
455
498
491

Technical Indicators

RSI(14)
Neutral
47.21
ATR(14)
Less Volatile
2.87
STOCH(9,6)
Neutral
25.77
STOCH RSI(14)
Oversold
6.77
MACD(12,26)
Bearish
-0.59
ADX(14)
Strong Trend
25.66
UO(9)
Bearish
31.99
ROC(12)
Uptrend And Accelerating
1.63
WillR(14)
Oversold
-81.53